Opus Reports Vision Improvements for Patients in LCA5 Gene Therapy Clinical Trial
Listen now
Description
Opus Reports Vision Improvements for Patients in LCA5 Gene Therapy Clinical Trial by Foundation Fighting Blindness
More Episodes
Dr. Peter Campochiaro, a clinician-scientist and the Eccles Professor of Ophthalmology and Neuroscience at the Johns Hopkins University School of Medicine, talks to host Ben Shaberman about N-acetylcysteine (NAC), a drug that shows promise for preserving cone vision (central vision and acuity) in...
Published 06/07/24
Published 06/07/24
Researchers believe the FDA-approved drug can reduce the hyperactivity of ganglion cells to improve vision.
Published 06/05/24